End-Stage Kidney Disease - Pipeline Insight, 2018

www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

Introduction to Report
 Launch Date: January 29, 2018
 Number of Pages: 50
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 1,250
Price For Site User License: USD 2,500
Price For Global User License: USD 4,000
Delivery Time: Within 24 Hours (During Working
Days)

About the Report
End-Stage Kidney Disease - Pipeline Insight, 2018
report offers comprehensive Insight of the pipeline
(under development) therapeutics scenario and
growth prospects across End-Stage Kidney
Disease development.
The report provides detailed coverage of the
pipeline landscape for this mechanism of action,
equipped with data from multiple sources with
complete pipeline analysis by developmental
stage, associated indications, route of
administration and molecule type.

Report Highlights;
Descriptive coverage of pipeline development
activities for End-Stage Kidney Disease Pipeline
therapeutics development coverage provides
descriptive product profiles including (but not
limited to) drug description, product development
and R&D activities encompassing clinical and pre-
clinical studies, designations, collaborations,
licensing deals, grants, technologies and patent
details.
Pipeline Therapeutics assessment of products for
End-Stage Kidney Disease.
The report assesses the active End-Stage Kidney
Disease pipeline products by developmental
stage, product type, molecule type, and
administration route.

Report Highlights; Continues…
Data used in the report are sourced primarily
from internal databases, primary and secondary
research and in-house analysis by DelveInsight’s
team of industry experts.
Information and data from the secondary sources
have been obtained from various printable and
non-printable sources like search engines, news
websites, global regulatory authorities websites,
trade journals, white papers, magazines, books,
trade associations, industry associations, industry
portals and access to available databases.

Scope;
The report provides a snapshot of the pipeline
development for the End-Stage Kidney Disease
The report covers pipeline activity across the complete
product development cycle i.e. clinical, pre-clinical and
discovery stages for the End-Stage Kidney Disease
The report provides pipeline product profiles which
includes product description, developmental activities,
licensors & collaborators and chemical information
Provides pipeline assessment by mono therapy and
combination therapy products, stage of development,
route of administration, and molecule type for End-
Stage Kidney Disease
The report also covers the dormant and discontinued
pipeline projects related to the End-Stage Kidney
Disease

Reasons to buy:
Establish comprehensive understanding of the
pipeline activity across this End-Stage Kidney
Disease to formulate effective R&D strategies
Gather information of the emerging competitors
having potentially lucrative portfolio in this space
and create effective counter strategies to gain
competitive advantage
Identify the relationship between the drugs and
use it for target finding, drug repurposing, and
precision medicine
Plot corrective measures for pipeline projects by
understanding the pipeline depth and focus of
End-Stage Kidney Disease therapeutics

Reasons to buy: Continues…
Devise in licensing and out licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and scope
Modify the therapeutic portfolio by identifying
inactive projects and understanding the factors
that might have halted their progress

Report Coverage:
1. Report Introduction
2. End-Stage Kidney Disease Overview
3. Pipeline Therapeutics
4. Comparative Analysis
5. Products in Clinical Stage
6. Products in Pre-Clinical and Discovery Stage
7. Therapeutic Assessment
8. Inactive Products
9. Appendix
For more details regarding Report coverage see the last slide

Company Coverage:
1. BLR Bio LLC
2. CTI Bio Pharma Corp
3. F. Hoffmann-La Roche Ltd
4. Novartis AG
5. Prolong Pharmaceuticals LLC
6. VESSL Therapeutics Ltd
7. & list continues
For more details regarding Report coverage see the last slide

Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter
at:
http://www.marketresearchreports.com/subscribe-to-
newsletter

How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/UW5
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Mr. Sudeep Chakravarty
Email : info@marketresearchreports.com
Phone: +1-302-703-9904 (USA) +91-8762746600 (India)

End-Stage Kidney Disease - Pipeline Insight, 2018

Recommended

Recommended

More Related Content

More from Market Research Reports, Inc.

More from Market Research Reports, Inc. (20)

Recently uploaded

Recently uploaded (20)

End-Stage Kidney Disease - Pipeline Insight, 2018